nodes	percent_of_prediction	percent_of_DWPC	metapath
Baclofen—Ibuprofen—PPARG—colon cancer	0.00737	0.3	CrCbGaD
Baclofen—Chlorphenesin—PTGS2—colon cancer	0.00697	0.283	CrCbGaD
Baclofen—Chlorpropamide—ABCB1—colon cancer	0.00449	0.183	CrCbGaD
Baclofen—Ibuprofen—PTGS2—colon cancer	0.00311	0.127	CrCbGaD
Baclofen—Ibuprofen—ABCB1—colon cancer	0.00265	0.108	CrCbGaD
Baclofen—Vertigo—Vincristine—colon cancer	0.00187	0.00192	CcSEcCtD
Baclofen—Vision blurred—Fluorouracil—colon cancer	0.00183	0.00188	CcSEcCtD
Baclofen—Malaise—Irinotecan—colon cancer	0.00183	0.00187	CcSEcCtD
Baclofen—Vertigo—Irinotecan—colon cancer	0.00182	0.00187	CcSEcCtD
Baclofen—Dysuria—Capecitabine—colon cancer	0.00182	0.00187	CcSEcCtD
Baclofen—Syncope—Irinotecan—colon cancer	0.00182	0.00186	CcSEcCtD
Baclofen—Convulsion—Vincristine—colon cancer	0.0018	0.00185	CcSEcCtD
Baclofen—Hypertension—Vincristine—colon cancer	0.0018	0.00184	CcSEcCtD
Baclofen—Anaemia—Fluorouracil—colon cancer	0.00179	0.00184	CcSEcCtD
Baclofen—Loss of consciousness—Irinotecan—colon cancer	0.00178	0.00183	CcSEcCtD
Baclofen—Myalgia—Vincristine—colon cancer	0.00177	0.00182	CcSEcCtD
Baclofen—Weight increased—Capecitabine—colon cancer	0.00177	0.00182	CcSEcCtD
Baclofen—Visual disturbance—Methotrexate—colon cancer	0.00177	0.00181	CcSEcCtD
Baclofen—Weight decreased—Capecitabine—colon cancer	0.00176	0.00181	CcSEcCtD
Baclofen—Hyperglycaemia—Capecitabine—colon cancer	0.00176	0.0018	CcSEcCtD
Baclofen—Hypertension—Irinotecan—colon cancer	0.00175	0.00179	CcSEcCtD
Baclofen—Pneumonia—Capecitabine—colon cancer	0.00175	0.00179	CcSEcCtD
Baclofen—Depression—Capecitabine—colon cancer	0.00173	0.00178	CcSEcCtD
Baclofen—Lethargy—Methotrexate—colon cancer	0.00171	0.00175	CcSEcCtD
Baclofen—Cerebrovascular accident—Methotrexate—colon cancer	0.00171	0.00175	CcSEcCtD
Baclofen—Renal failure—Capecitabine—colon cancer	0.00171	0.00175	CcSEcCtD
Baclofen—Discomfort—Irinotecan—colon cancer	0.00171	0.00175	CcSEcCtD
Baclofen—Oedema—Vincristine—colon cancer	0.0017	0.00174	CcSEcCtD
Baclofen—Infection—Vincristine—colon cancer	0.00169	0.00173	CcSEcCtD
Baclofen—Convulsion—Fluorouracil—colon cancer	0.00168	0.00172	CcSEcCtD
Baclofen—Osteoarthritis—Methotrexate—colon cancer	0.00168	0.00172	CcSEcCtD
Baclofen—Confusional state—Irinotecan—colon cancer	0.00167	0.00171	CcSEcCtD
Baclofen—Nervous system disorder—Vincristine—colon cancer	0.00167	0.00171	CcSEcCtD
Baclofen—Haematuria—Capecitabine—colon cancer	0.00166	0.0017	CcSEcCtD
Baclofen—Oedema—Irinotecan—colon cancer	0.00165	0.0017	CcSEcCtD
Baclofen—Chest pain—Fluorouracil—colon cancer	0.00165	0.00169	CcSEcCtD
Baclofen—Myalgia—Fluorouracil—colon cancer	0.00165	0.00169	CcSEcCtD
Baclofen—Infection—Irinotecan—colon cancer	0.00164	0.00169	CcSEcCtD
Baclofen—Hyperhidrosis—Vincristine—colon cancer	0.00164	0.00168	CcSEcCtD
Baclofen—Hepatobiliary disease—Capecitabine—colon cancer	0.00164	0.00168	CcSEcCtD
Baclofen—Discomfort—Fluorouracil—colon cancer	0.00163	0.00167	CcSEcCtD
Baclofen—Shock—Irinotecan—colon cancer	0.00163	0.00167	CcSEcCtD
Baclofen—Nervous system disorder—Irinotecan—colon cancer	0.00162	0.00166	CcSEcCtD
Baclofen—Anorexia—Vincristine—colon cancer	0.00162	0.00166	CcSEcCtD
Baclofen—Hyperhidrosis—Irinotecan—colon cancer	0.0016	0.00164	CcSEcCtD
Baclofen—Confusional state—Fluorouracil—colon cancer	0.0016	0.00164	CcSEcCtD
Baclofen—Mood swings—Methotrexate—colon cancer	0.00159	0.00163	CcSEcCtD
Baclofen—Hypotension—Vincristine—colon cancer	0.00159	0.00163	CcSEcCtD
Baclofen—Bradycardia—Capecitabine—colon cancer	0.00159	0.00163	CcSEcCtD
Baclofen—Oedema—Fluorouracil—colon cancer	0.00158	0.00162	CcSEcCtD
Baclofen—Anorexia—Irinotecan—colon cancer	0.00158	0.00162	CcSEcCtD
Baclofen—Ataxia—Methotrexate—colon cancer	0.00158	0.00162	CcSEcCtD
Baclofen—Infection—Fluorouracil—colon cancer	0.00157	0.00161	CcSEcCtD
Baclofen—Rhinitis—Capecitabine—colon cancer	0.00156	0.0016	CcSEcCtD
Baclofen—Nervous system disorder—Fluorouracil—colon cancer	0.00155	0.00159	CcSEcCtD
Baclofen—Hypoaesthesia—Capecitabine—colon cancer	0.00155	0.00159	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Vincristine—colon cancer	0.00155	0.00159	CcSEcCtD
Baclofen—Tachycardia—Fluorouracil—colon cancer	0.00155	0.00159	CcSEcCtD
Baclofen—Hypotension—Irinotecan—colon cancer	0.00155	0.00159	CcSEcCtD
Baclofen—Urinary tract disorder—Capecitabine—colon cancer	0.00154	0.00158	CcSEcCtD
Baclofen—Insomnia—Vincristine—colon cancer	0.00154	0.00158	CcSEcCtD
Baclofen—Oedema peripheral—Capecitabine—colon cancer	0.00154	0.00157	CcSEcCtD
Baclofen—Connective tissue disorder—Capecitabine—colon cancer	0.00153	0.00157	CcSEcCtD
Baclofen—Urethral disorder—Capecitabine—colon cancer	0.00153	0.00157	CcSEcCtD
Baclofen—Paraesthesia—Vincristine—colon cancer	0.00153	0.00156	CcSEcCtD
Baclofen—Breast disorder—Methotrexate—colon cancer	0.00152	0.00155	CcSEcCtD
Baclofen—Anorexia—Fluorouracil—colon cancer	0.00151	0.00155	CcSEcCtD
Baclofen—Visual impairment—Capecitabine—colon cancer	0.0015	0.00154	CcSEcCtD
Baclofen—Insomnia—Irinotecan—colon cancer	0.0015	0.00153	CcSEcCtD
Baclofen—Paraesthesia—Irinotecan—colon cancer	0.00149	0.00152	CcSEcCtD
Baclofen—Hypotension—Fluorouracil—colon cancer	0.00148	0.00152	CcSEcCtD
Baclofen—Decreased appetite—Vincristine—colon cancer	0.00148	0.00151	CcSEcCtD
Baclofen—Dyspnoea—Irinotecan—colon cancer	0.00148	0.00151	CcSEcCtD
Baclofen—Somnolence—Irinotecan—colon cancer	0.00147	0.00151	CcSEcCtD
Baclofen—Gastrointestinal disorder—Vincristine—colon cancer	0.00147	0.0015	CcSEcCtD
Baclofen—Fatigue—Vincristine—colon cancer	0.00146	0.0015	CcSEcCtD
Baclofen—Eye disorder—Capecitabine—colon cancer	0.00146	0.00149	CcSEcCtD
Baclofen—Dyspepsia—Irinotecan—colon cancer	0.00146	0.00149	CcSEcCtD
Baclofen—Tinnitus—Capecitabine—colon cancer	0.00145	0.00149	CcSEcCtD
Baclofen—Pain—Vincristine—colon cancer	0.00145	0.00149	CcSEcCtD
Baclofen—Constipation—Vincristine—colon cancer	0.00145	0.00149	CcSEcCtD
Baclofen—Cardiac disorder—Capecitabine—colon cancer	0.00145	0.00148	CcSEcCtD
Baclofen—Flushing—Capecitabine—colon cancer	0.00145	0.00148	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00144	0.00148	CcSEcCtD
Baclofen—Decreased appetite—Irinotecan—colon cancer	0.00144	0.00147	CcSEcCtD
Baclofen—Insomnia—Fluorouracil—colon cancer	0.00143	0.00147	CcSEcCtD
Baclofen—Gastrointestinal disorder—Irinotecan—colon cancer	0.00143	0.00146	CcSEcCtD
Baclofen—Fatigue—Irinotecan—colon cancer	0.00143	0.00146	CcSEcCtD
Baclofen—Paraesthesia—Fluorouracil—colon cancer	0.00142	0.00146	CcSEcCtD
Baclofen—Pain—Irinotecan—colon cancer	0.00141	0.00145	CcSEcCtD
Baclofen—Constipation—Irinotecan—colon cancer	0.00141	0.00145	CcSEcCtD
Baclofen—Angiopathy—Capecitabine—colon cancer	0.00141	0.00145	CcSEcCtD
Baclofen—Dyspnoea—Fluorouracil—colon cancer	0.00141	0.00145	CcSEcCtD
Baclofen—Somnolence—Fluorouracil—colon cancer	0.00141	0.00144	CcSEcCtD
Baclofen—Mediastinal disorder—Capecitabine—colon cancer	0.0014	0.00144	CcSEcCtD
Baclofen—Chills—Capecitabine—colon cancer	0.0014	0.00143	CcSEcCtD
Baclofen—Dyspepsia—Fluorouracil—colon cancer	0.0014	0.00143	CcSEcCtD
Baclofen—Arrhythmia—Capecitabine—colon cancer	0.00139	0.00143	CcSEcCtD
Baclofen—Gastrointestinal pain—Vincristine—colon cancer	0.00139	0.00142	CcSEcCtD
Baclofen—Decreased appetite—Fluorouracil—colon cancer	0.00138	0.00141	CcSEcCtD
Baclofen—Alopecia—Capecitabine—colon cancer	0.00138	0.00141	CcSEcCtD
Baclofen—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00137	0.0014	CcSEcCtD
Baclofen—Mental disorder—Capecitabine—colon cancer	0.00137	0.0014	CcSEcCtD
Baclofen—Feeling abnormal—Irinotecan—colon cancer	0.00136	0.0014	CcSEcCtD
Baclofen—Malnutrition—Capecitabine—colon cancer	0.00136	0.00139	CcSEcCtD
Baclofen—Dysuria—Methotrexate—colon cancer	0.00136	0.00139	CcSEcCtD
Baclofen—Pain—Fluorouracil—colon cancer	0.00136	0.00139	CcSEcCtD
Baclofen—Gastrointestinal pain—Irinotecan—colon cancer	0.00135	0.00139	CcSEcCtD
Baclofen—Body temperature increased—Vincristine—colon cancer	0.00134	0.00138	CcSEcCtD
Baclofen—Abdominal pain—Vincristine—colon cancer	0.00134	0.00138	CcSEcCtD
Baclofen—Flatulence—Capecitabine—colon cancer	0.00134	0.00137	CcSEcCtD
Baclofen—Erectile dysfunction—Methotrexate—colon cancer	0.00134	0.00137	CcSEcCtD
Baclofen—Dysgeusia—Capecitabine—colon cancer	0.00133	0.00136	CcSEcCtD
Baclofen—Back pain—Capecitabine—colon cancer	0.00131	0.00135	CcSEcCtD
Baclofen—Abdominal pain—Irinotecan—colon cancer	0.00131	0.00134	CcSEcCtD
Baclofen—Body temperature increased—Irinotecan—colon cancer	0.00131	0.00134	CcSEcCtD
Baclofen—Feeling abnormal—Fluorouracil—colon cancer	0.00131	0.00134	CcSEcCtD
Baclofen—Pneumonia—Methotrexate—colon cancer	0.0013	0.00133	CcSEcCtD
Baclofen—Drowsiness—Methotrexate—colon cancer	0.00129	0.00133	CcSEcCtD
Baclofen—Depression—Methotrexate—colon cancer	0.00129	0.00132	CcSEcCtD
Baclofen—Vision blurred—Capecitabine—colon cancer	0.00128	0.00131	CcSEcCtD
Baclofen—Tremor—Capecitabine—colon cancer	0.00127	0.0013	CcSEcCtD
Baclofen—Renal failure—Methotrexate—colon cancer	0.00127	0.0013	CcSEcCtD
Baclofen—Ill-defined disorder—Capecitabine—colon cancer	0.00126	0.00129	CcSEcCtD
Baclofen—Urticaria—Fluorouracil—colon cancer	0.00126	0.00129	CcSEcCtD
Baclofen—Anaemia—Capecitabine—colon cancer	0.00125	0.00129	CcSEcCtD
Baclofen—Body temperature increased—Fluorouracil—colon cancer	0.00125	0.00128	CcSEcCtD
Baclofen—Sweating—Methotrexate—colon cancer	0.00124	0.00127	CcSEcCtD
Baclofen—Haematuria—Methotrexate—colon cancer	0.00123	0.00126	CcSEcCtD
Baclofen—Malaise—Capecitabine—colon cancer	0.00122	0.00125	CcSEcCtD
Baclofen—Hepatobiliary disease—Methotrexate—colon cancer	0.00122	0.00125	CcSEcCtD
Baclofen—Vertigo—Capecitabine—colon cancer	0.00122	0.00125	CcSEcCtD
Baclofen—Asthenia—Vincristine—colon cancer	0.00122	0.00125	CcSEcCtD
Baclofen—Syncope—Capecitabine—colon cancer	0.00122	0.00125	CcSEcCtD
Baclofen—Palpitations—Capecitabine—colon cancer	0.0012	0.00123	CcSEcCtD
Baclofen—Loss of consciousness—Capecitabine—colon cancer	0.00119	0.00122	CcSEcCtD
Baclofen—Asthenia—Irinotecan—colon cancer	0.00119	0.00122	CcSEcCtD
Baclofen—Hypertension—Capecitabine—colon cancer	0.00117	0.0012	CcSEcCtD
Baclofen—Diarrhoea—Vincristine—colon cancer	0.00116	0.00119	CcSEcCtD
Baclofen—Chest pain—Capecitabine—colon cancer	0.00116	0.00118	CcSEcCtD
Baclofen—Myalgia—Capecitabine—colon cancer	0.00116	0.00118	CcSEcCtD
Baclofen—Anxiety—Capecitabine—colon cancer	0.00115	0.00118	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00115	0.00118	CcSEcCtD
Baclofen—Urinary tract disorder—Methotrexate—colon cancer	0.00115	0.00117	CcSEcCtD
Baclofen—Discomfort—Capecitabine—colon cancer	0.00114	0.00117	CcSEcCtD
Baclofen—Urethral disorder—Methotrexate—colon cancer	0.00114	0.00117	CcSEcCtD
Baclofen—Diarrhoea—Irinotecan—colon cancer	0.00113	0.00116	CcSEcCtD
Baclofen—Dry mouth—Capecitabine—colon cancer	0.00113	0.00116	CcSEcCtD
Baclofen—Dizziness—Vincristine—colon cancer	0.00112	0.00115	CcSEcCtD
Baclofen—Pruritus—Fluorouracil—colon cancer	0.00112	0.00115	CcSEcCtD
Baclofen—Visual impairment—Methotrexate—colon cancer	0.00112	0.00115	CcSEcCtD
Baclofen—Confusional state—Capecitabine—colon cancer	0.00112	0.00114	CcSEcCtD
Baclofen—Oedema—Capecitabine—colon cancer	0.00111	0.00114	CcSEcCtD
Baclofen—Infection—Capecitabine—colon cancer	0.0011	0.00113	CcSEcCtD
Baclofen—Dizziness—Irinotecan—colon cancer	0.00109	0.00112	CcSEcCtD
Baclofen—Shock—Capecitabine—colon cancer	0.00109	0.00112	CcSEcCtD
Baclofen—Nervous system disorder—Capecitabine—colon cancer	0.00109	0.00111	CcSEcCtD
Baclofen—Eye disorder—Methotrexate—colon cancer	0.00108	0.00111	CcSEcCtD
Baclofen—Diarrhoea—Fluorouracil—colon cancer	0.00108	0.00111	CcSEcCtD
Baclofen—Tinnitus—Methotrexate—colon cancer	0.00108	0.00111	CcSEcCtD
Baclofen—Tachycardia—Capecitabine—colon cancer	0.00108	0.00111	CcSEcCtD
Baclofen—Vomiting—Vincristine—colon cancer	0.00108	0.00111	CcSEcCtD
Baclofen—Cardiac disorder—Methotrexate—colon cancer	0.00108	0.0011	CcSEcCtD
Baclofen—Skin disorder—Capecitabine—colon cancer	0.00108	0.0011	CcSEcCtD
Baclofen—Rash—Vincristine—colon cancer	0.00107	0.0011	CcSEcCtD
Baclofen—Hyperhidrosis—Capecitabine—colon cancer	0.00107	0.0011	CcSEcCtD
Baclofen—Dermatitis—Vincristine—colon cancer	0.00107	0.0011	CcSEcCtD
Baclofen—Headache—Vincristine—colon cancer	0.00106	0.00109	CcSEcCtD
Baclofen—Anorexia—Capecitabine—colon cancer	0.00106	0.00108	CcSEcCtD
Baclofen—Angiopathy—Methotrexate—colon cancer	0.00105	0.00108	CcSEcCtD
Baclofen—Vomiting—Irinotecan—colon cancer	0.00105	0.00108	CcSEcCtD
Baclofen—Dizziness—Fluorouracil—colon cancer	0.00105	0.00107	CcSEcCtD
Baclofen—Mediastinal disorder—Methotrexate—colon cancer	0.00105	0.00107	CcSEcCtD
Baclofen—Rash—Irinotecan—colon cancer	0.00104	0.00107	CcSEcCtD
Baclofen—Dermatitis—Irinotecan—colon cancer	0.00104	0.00107	CcSEcCtD
Baclofen—Chills—Methotrexate—colon cancer	0.00104	0.00107	CcSEcCtD
Baclofen—Headache—Irinotecan—colon cancer	0.00104	0.00106	CcSEcCtD
Baclofen—Hypotension—Capecitabine—colon cancer	0.00103	0.00106	CcSEcCtD
Baclofen—Alopecia—Methotrexate—colon cancer	0.00103	0.00105	CcSEcCtD
Baclofen—Mental disorder—Methotrexate—colon cancer	0.00102	0.00104	CcSEcCtD
Baclofen—Malnutrition—Methotrexate—colon cancer	0.00101	0.00104	CcSEcCtD
Baclofen—Nausea—Vincristine—colon cancer	0.00101	0.00103	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00101	0.00103	CcSEcCtD
Baclofen—Vomiting—Fluorouracil—colon cancer	0.00101	0.00103	CcSEcCtD
Baclofen—Insomnia—Capecitabine—colon cancer	0.001	0.00103	CcSEcCtD
Baclofen—Rash—Fluorouracil—colon cancer	0.000999	0.00102	CcSEcCtD
Baclofen—Dermatitis—Fluorouracil—colon cancer	0.000998	0.00102	CcSEcCtD
Baclofen—Paraesthesia—Capecitabine—colon cancer	0.000994	0.00102	CcSEcCtD
Baclofen—Headache—Fluorouracil—colon cancer	0.000993	0.00102	CcSEcCtD
Baclofen—Dysgeusia—Methotrexate—colon cancer	0.000989	0.00101	CcSEcCtD
Baclofen—Dyspnoea—Capecitabine—colon cancer	0.000987	0.00101	CcSEcCtD
Baclofen—Nausea—Irinotecan—colon cancer	0.000983	0.00101	CcSEcCtD
Baclofen—Back pain—Methotrexate—colon cancer	0.000977	0.001	CcSEcCtD
Baclofen—Dyspepsia—Capecitabine—colon cancer	0.000975	0.000999	CcSEcCtD
Baclofen—Decreased appetite—Capecitabine—colon cancer	0.000963	0.000987	CcSEcCtD
Baclofen—Gastrointestinal disorder—Capecitabine—colon cancer	0.000956	0.00098	CcSEcCtD
Baclofen—Fatigue—Capecitabine—colon cancer	0.000955	0.000979	CcSEcCtD
Baclofen—Vision blurred—Methotrexate—colon cancer	0.000952	0.000976	CcSEcCtD
Baclofen—Pain—Capecitabine—colon cancer	0.000947	0.000971	CcSEcCtD
Baclofen—Constipation—Capecitabine—colon cancer	0.000947	0.000971	CcSEcCtD
Baclofen—Nausea—Fluorouracil—colon cancer	0.000941	0.000965	CcSEcCtD
Baclofen—Ill-defined disorder—Methotrexate—colon cancer	0.000937	0.000961	CcSEcCtD
Baclofen—Anaemia—Methotrexate—colon cancer	0.000934	0.000957	CcSEcCtD
Baclofen—Feeling abnormal—Capecitabine—colon cancer	0.000913	0.000936	CcSEcCtD
Baclofen—Malaise—Methotrexate—colon cancer	0.000911	0.000934	CcSEcCtD
Baclofen—Vertigo—Methotrexate—colon cancer	0.000908	0.00093	CcSEcCtD
Baclofen—Gastrointestinal pain—Capecitabine—colon cancer	0.000906	0.000928	CcSEcCtD
Baclofen—Urticaria—Capecitabine—colon cancer	0.00088	0.000902	CcSEcCtD
Baclofen—Abdominal pain—Capecitabine—colon cancer	0.000875	0.000898	CcSEcCtD
Baclofen—Body temperature increased—Capecitabine—colon cancer	0.000875	0.000898	CcSEcCtD
Baclofen—Convulsion—Methotrexate—colon cancer	0.000875	0.000897	CcSEcCtD
Baclofen—Chest pain—Methotrexate—colon cancer	0.00086	0.000882	CcSEcCtD
Baclofen—Myalgia—Methotrexate—colon cancer	0.00086	0.000882	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000854	0.000876	CcSEcCtD
Baclofen—Discomfort—Methotrexate—colon cancer	0.00085	0.000871	CcSEcCtD
Baclofen—Confusional state—Methotrexate—colon cancer	0.000831	0.000852	CcSEcCtD
Baclofen—Infection—Methotrexate—colon cancer	0.000819	0.00084	CcSEcCtD
Baclofen—Nervous system disorder—Methotrexate—colon cancer	0.000808	0.000829	CcSEcCtD
Baclofen—Skin disorder—Methotrexate—colon cancer	0.000801	0.000821	CcSEcCtD
Baclofen—Hyperhidrosis—Methotrexate—colon cancer	0.000797	0.000817	CcSEcCtD
Baclofen—Asthenia—Capecitabine—colon cancer	0.000795	0.000815	CcSEcCtD
Baclofen—Anorexia—Methotrexate—colon cancer	0.000786	0.000806	CcSEcCtD
Baclofen—Pruritus—Capecitabine—colon cancer	0.000784	0.000803	CcSEcCtD
Baclofen—Hypotension—Methotrexate—colon cancer	0.00077	0.00079	CcSEcCtD
Baclofen—Diarrhoea—Capecitabine—colon cancer	0.000758	0.000777	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000751	0.00077	CcSEcCtD
Baclofen—Insomnia—Methotrexate—colon cancer	0.000746	0.000764	CcSEcCtD
Baclofen—Paraesthesia—Methotrexate—colon cancer	0.00074	0.000759	CcSEcCtD
Baclofen—Dyspnoea—Methotrexate—colon cancer	0.000735	0.000754	CcSEcCtD
Baclofen—Somnolence—Methotrexate—colon cancer	0.000733	0.000751	CcSEcCtD
Baclofen—Dizziness—Capecitabine—colon cancer	0.000732	0.000751	CcSEcCtD
Baclofen—Dyspepsia—Methotrexate—colon cancer	0.000726	0.000744	CcSEcCtD
Baclofen—Decreased appetite—Methotrexate—colon cancer	0.000717	0.000735	CcSEcCtD
Baclofen—Gastrointestinal disorder—Methotrexate—colon cancer	0.000712	0.00073	CcSEcCtD
Baclofen—Fatigue—Methotrexate—colon cancer	0.000711	0.000729	CcSEcCtD
Baclofen—Pain—Methotrexate—colon cancer	0.000705	0.000723	CcSEcCtD
Baclofen—Vomiting—Capecitabine—colon cancer	0.000704	0.000722	CcSEcCtD
Baclofen—Rash—Capecitabine—colon cancer	0.000698	0.000716	CcSEcCtD
Baclofen—Dermatitis—Capecitabine—colon cancer	0.000698	0.000715	CcSEcCtD
Baclofen—Headache—Capecitabine—colon cancer	0.000694	0.000711	CcSEcCtD
Baclofen—Feeling abnormal—Methotrexate—colon cancer	0.000679	0.000696	CcSEcCtD
Baclofen—Gastrointestinal pain—Methotrexate—colon cancer	0.000674	0.000691	CcSEcCtD
Baclofen—Nausea—Capecitabine—colon cancer	0.000658	0.000674	CcSEcCtD
Baclofen—Urticaria—Methotrexate—colon cancer	0.000655	0.000671	CcSEcCtD
Baclofen—Abdominal pain—Methotrexate—colon cancer	0.000652	0.000668	CcSEcCtD
Baclofen—Body temperature increased—Methotrexate—colon cancer	0.000652	0.000668	CcSEcCtD
Baclofen—Asthenia—Methotrexate—colon cancer	0.000591	0.000606	CcSEcCtD
Baclofen—Pruritus—Methotrexate—colon cancer	0.000583	0.000598	CcSEcCtD
Baclofen—Diarrhoea—Methotrexate—colon cancer	0.000564	0.000578	CcSEcCtD
Baclofen—Dizziness—Methotrexate—colon cancer	0.000545	0.000559	CcSEcCtD
Baclofen—Vomiting—Methotrexate—colon cancer	0.000524	0.000537	CcSEcCtD
Baclofen—Rash—Methotrexate—colon cancer	0.00052	0.000533	CcSEcCtD
Baclofen—Dermatitis—Methotrexate—colon cancer	0.000519	0.000532	CcSEcCtD
Baclofen—Headache—Methotrexate—colon cancer	0.000516	0.000529	CcSEcCtD
Baclofen—Nausea—Methotrexate—colon cancer	0.00049	0.000502	CcSEcCtD
